ITPKB and autoimmune disease: The T and B cell defects in germline Itpkb−/− mice sparked efforts to develop specific and selective Itpkb small-molecule inhibitors as potential therapeutics for autoimmune disorders or transplant rejection, reviewed in detail in Ref.